Letter to Congress from PanCAN President and CEO Julie Fleshman in Response to President Trump’s Proposed Budget Cuts to the National Institutes of Health
Two out of every five Americans will be diagnosed with cancer in their lifetime. These are sobering statistics that remind […]
READ MORE
PanCAN Announces a Strategic Alliance with GCAR for Precision Promise
Happy New Year! I am excited to share with you an update about Precision Promise, our adaptive clinical trial platform […]
READ MORE
Our Statement on Diversity and Inclusion from PanCAN’s CEO
Dear PanCAN Community: Now more than ever, we all have an obligation to combat racism and to consider our personal […]
READ MORE
A Message from PanCAN’s CEO
Dear PanCAN Community: We stand together with the Black community, now and always. It is hard to find the right […]
READ MORE
A Message from Our PanCAN CEO
Editor’s note: The original message from our president and CEO Julie Fleshman, first published in March 2020, has been updated. […]
READ MORE
When the Patient Advocate Becomes the Patient
Editor’s note: Julie Fleshman, JD, MBA, is the president and CEO of the Pancreatic Cancer Action Network (PanCAN). Under her […]
READ MORE












